Filter
1780
Filtered Results: 1780
Text search:
World
Health
Organization,
Regional
Office
South-East
Asia
Featured
Recommendations
157
New Publications
479
Language
Document type
No document type
935
Studies & Reports
409
Guidelines
200
Manuals
91
Strategic & Response Plan
70
Training Material
21
Fact sheets
17
Situation Updates
16
Resource Platforms
11
Infographics
6
Brochures
2
Online Courses
2
Countries / Regions
Global
114
South–East Asia Region
72
Myanmar / Burma
70
India
69
Nepal
49
Asia
44
Bangladesh
34
Philippines
31
Western and Central Europe
30
Indonesia
28
Africa
24
Cambodia
21
Ethiopia
20
Uganda
18
Kenya
17
Western Pacific Region
15
Syria
14
Middle East and North Africa
14
Liberia
13
Tanzania
13
Thailand
13
South Africa
12
Pakistan
11
Ukraine
11
Eastern Europe
11
Ghana
10
Zambia
10
Afghanistan
9
Latin America and the Carribbean
9
Sierra Leone
8
Nigeria
8
Malawi
8
West and Central Africa
8
Congo, Democratic Republic of
7
Haiti
7
Rwanda
7
Mozambique
7
Yemen
7
East and Southern Africa
7
China
6
Sri Lanka
6
Laos
6
Russia
6
Senegal
5
Zimbabwe
5
Somalia
5
South Sudan
5
Sudan
5
Eastern Europe and Central Asia
5
Turkey
4
Papua New Guinea
4
Venezuela
4
Moldova
4
Vietnam
4
Guinea
3
Burkina Faso
3
Jordan
3
Central African Republic
3
Eswatini/ Swaziland
3
North Macedonia
3
Timor Leste/ East Timor
3
Georgia
3
USA
2
Cameroon
2
Iraq
2
Lebanon
2
Malaysia
2
Mexico
2
Bhutan
2
Albania
2
Iran
2
Kazakhstan
2
Belarus
2
Bosnia and Herzegovina
2
Mali
1
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
Egypt
1
Chad
1
Singapore
1
Argentina
1
Namibia
1
Peru
1
Brazil
1
Hungary
1
Croatia
1
Colombia
1
Ecuador
1
Botswana
1
Greece
1
Angola
1
Madagascar
1
Lesotho
1
Other region
1
Paraguay
1
Poland
1
Palestine
1
North Korea
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Tajikistan
1
Qatar
1
Romania
1
Kyrgyzstan
1
North America
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
452
Clinical Guidelines
192
Public Health
130
Women & Child Health
129
Key Resources
95
Capacity Building
36
Pharmacy & Technologies
21
Toolboxes
HIV
174
Mental Health
144
COVID-19
128
Planetary Health
112
TB
83
Rapid Response
77
AMR
63
NTDs
63
Global Health Education
59
Disability
56
Refugee
45
Caregiver
42
Natural Hazards
33
NCDs
33
Conflict
30
Health Financing Toolbox
28
Zika
20
Pharmacy
20
Ebola
17
Polio
12
Cholera
9
Specific Hazards
9
Typhoon
3
Social Ethics
1
Health Financing
1
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the op...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and pe...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
The global burden of disease associated with air pollution exposure exacts a massive toll on human health worldwide: exposure to air pollution is estimated to cause millions of deaths and lost years of hea... life annually. The burden of disease attributable to air pollution is now estimated to be on a par with other major global health risks such as unhealthy diet and tobacco smoking, and air pollution is now recognized as the single biggest environmental threat to human health.
WHO Technical Series 971
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigma...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment cri...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
WHO’s Ambition and Action in Nutrition 2016-2025 is anchored in the six global targets for improving maternal, infant and young child nutrition and the global diet-related NCD targets.
In support of the 2030 Agenda for Sustainable Development, particularly SDG2 and SDG3, and in concert w...
In support of the 2030 Agenda for Sustainable Development, particularly SDG2 and SDG3, and in concert w...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets...
Building laboratory testing capacity
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
Rapid Advice Guideline
Eradication of yaws in India | Éradication du pian en Inde - 17 April 2015, 90th Year / 17 Avril 2015, 90e Année | No. 16, 2015, 90, 161–168 | http://www.who.int/wer
The purpose of this handbook is to provide guidance to Member States on the practical aspects of maintaining sanitary standards at international borders at ports, airports, and ground crossings (points of entry) as set out in the International Health...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
Guidelines for malaria vector control
recommended
these guidelines are updated on 16 February 2021
Please check the new guideline here
https://medbox.org/document/who-guidelines-for-malaria#GO
